Search for asset offerings and demands from relevant innovative medicine players

Check out asset profile data including project status but excluding company's name

Understand your partner's capabilities and aspired deal structure


Invite your team and cross-functional experts to assess interesting opportunities

Identify key questions and road blocks early on in the evaluation process

Create alignment on priorities with key internal stakeholders


Communicate incognito with the asset owner in a safe and secure chat room

Investigate further asset details and deal parameters to finalize pre-assessment

Exchange contact data mutually when there is the right level of confidence

Quick guide through the functionalities


Search innovative medicine and R&D licensing opportunities based on well structured asset information

  • Asset summary view is providing all key information like molecule type, target, therapeutic area, development phase,  pathway, technology and IP status
  • Obtain project detailed status information: What project steps and sub-steps have been achieved so far and what is planned in future
  • Company name and information may or may not be published depending on the asset holders preference to keep asset information confidential
  • Understand playing field expectations on deal structure, capabilities, and geography

Evaluate opportunities with cross-functional team

  • Use bioseet platform asset notifications to raise your team´s attention on high value BD&L opportunities
  • Vote and comment directly on assets and leverage traffic light information to speed up the assessment process
  • Setup your asset related project team and drive detailed and confidential asset evaluation in a secluded chat room

Exchange information with external partner to validate the asset opportunity

  • Create asset projects for external partner exchanges and use project lists to keep an overview on project status
  • Leverage a safe and secure chat room for anonymous external partner exchange to validate all asset and partner information
  • Use mutual opt-in mechanism for identity disclosure and exchange contact information to pursue further dealmaking process offline

Book a Demo